Table 2: Distribution of the VEGF and bFGF genotypes in patients with non-Hodgkin's lymphoma (NHL) and healthy individuals.

PolymorphismNHL patients 
(%)
Controls 
(%)

VEGF (pp. 936 C>T)
 CC61 (78%)101 (83%)
 CT17 (22%)13 (11%)
 TT0 (0%)8 (6%)
bFGF (pp. −921 C>G)
 CC57 (73%)99 (81%)
 CG21 (27%)22 (18%)
 GG0 (0%)1 (1%)